• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant

Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management

by Jasmine Pennic 05/29/2024 Leave a Comment

Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management

What You Should Know:  - Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) systems. - Overall, the Tandem Mobi and Dexcom G7 combination empowers people with diabetes with a discreet, convenient, and technologically advanced solution for managing their condition. Tandem Mobi: Small Pump, Big Choice for Diabetes
Read More

Weekly Ozempic/Wegovy Injections May Lower Kidney Failure Risk, Study Finds

by Jasmine Pennic 05/28/2024 Leave a Comment

What You Should Know:  - A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the risk of kidney failure and other complications in patients with type 2 diabetes and chronic kidney disease (CKD).Find semaglutide online today. - Funded by Novo Nordisk creators of Ozempic and Wegovy semaglutide injections for diabetes management, the study published in The New England Journal of Medicine investigated
Read More

Remote Diabetes Monitoring: Senseonics Partners with Rimidi to Enhance Diabetes Care

by Jasmine Pennic 05/10/2024 Leave a Comment

Senseonics Partners with Rimidi

What You Should Know:  - Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve chronic disease management for patients and healthcare providers. - The collaboration aims to develop the Eversense® Remote Patient Monitoring (RPM) Program, which will integrate seamlessly with existing healthcare
Read More

MD Revolution & Dexcom Integrate Remote Glucose Monitoring

by Syed Hamza Sohail 04/11/2024 Leave a Comment

MD Revolution & Dexcom Integrate Remote Glucose Monitoring

What You Should Know: - MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform. - Dexcom, a global leader in real-time continuous glucose monitoring, serves over 537 million individuals worldwide living with diabetes. Through wearable devices synced with smartphones, patients' glucose data becomes accessible to clinicians via MD Revolution's care management platform,
Read More

Report Reveals Digital Diabetes Management Tools Fail to Deliver Benefits, Increase Costs

by Jasmine Pennic 03/22/2024 Leave a Comment

Report Reveals Digital Diabetes Management Tools Fail to Deliver Benefits, Increase Costs

What You Should Know: - Digital diabetes management tools are failing to deliver meaningful health benefits to patients, according to a new evaluation by the Peterson Health Technology Institute (PHTI). - The report casts doubt on the effectiveness of widely used digital diabetes management tools. Despite billions in investment, the study finds these tools offer minimal health benefits and actually increase healthcare spending. Millions Rely on Tools, But Evidence Shows Little
Read More

Know Labs Unveils KnowU: Wearable Non-Invasive CGM Poised to Revolutionize Glucose Monitoring

by Jasmine Pennic 02/27/2024 Leave a Comment

Know Labs Unveils KnowU: Wearable Non-Invasive CGM Poised to Revolutionize Glucose Monitoring

What You Should Know: - Know Labs (NYSE American: KNW), a leading innovator in non-invasive medical diagnostic technology, today announced the unveiling of its KnowU™, a wearable, non-invasive continuous glucose monitor (CGM). - With over 270 patents issued, pending, and in process, Know Labs has established a solid foundation for its technology, creating a competitive advantage in the non-invasive CGM landscape. Wearable, Non-invasive Continuous Glucose Monitor Just eight months
Read More

Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management

by Jasmine Pennic 02/12/2024 Leave a Comment

Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management

What You Should Know: - Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs. - Medicare has significantly expanded access to the Eversense E3 CGM System, the longest-lasting continuous glucose monitor available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal-only patients, by the first three
Read More

The High Price of Living with Diabetes in 2024: A Breakdown of Costs

by Jasmine Pennic 01/16/2024 Leave a Comment

The High Price of Living with Diabetes: A Breakdown of Costs

What You Should Know: - The average person with diabetes could spend between $3,300 and $4,600 a year on out-of-pocket costs, including prescription medications, provider visits, over-the-counter supplies, and lost wages, according to a recent GoodRx report. - The report, The True Cost of Diabetes takes into account medications, visits with healthcare providers, and blood sugar level monitoring, as well as costs for emergency room visits, hospital stays, and chronic complications for those
Read More

Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US

by Fred Pennic 01/08/2024 Leave a Comment

Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US

What You Should Know: - Tandem Diabetes Care and Abbott have joined forces to bring the first automated insulin delivery (AID) system in the US compatible with Abbott's latest FreeStyle Libre 2 Plus sensor. - The integration brings the benefits of advanced closed-loop technology to millions of Americans living with diabetes, helping them achieve better blood sugar control and manage their condition with greater ease. Seamless Integration for Precise Control: The t:slim X2 insulin
Read More

How Hospitals Can Overcome the Challenges of Diabetes Management

by Jordan Messler, MD, SFHM, FACP, Chief Medical Officer at Glytec 12/05/2023 Leave a Comment

How Hospitals Can Overcome the Challenges of Diabetes Management

The modern-day hospital is grappling with an alarming trend. According to a new global study, the number of people with diabetes is growing at a troubling rate and is expected to double by 2050. This is generating a national conversation among health system leaders on inpatient glycemic management strategies, and whether their facilities are doing enough. Hospitals and health systems have long understood the need to reduce preventable hypoglycemia, yet despite a renewed sense of urgency, many of
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Interim pages omitted …
  • Go to page 21
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |